Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Robert K. Zeldin | CHIEF MEDICAL OFFICER | 2025-02-21 | 5,903 | $7.30 | $43.09kSell |
Alexandria Forbes | PRESIDENT CEO | 2025-02-21 | 66,095 | $7.30 | $482.49kSell |
Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | 2025-02-21 | 12,116 | $7.30 | $88.45kSell |
Richard Giroux | CFO COO | 2025-02-21 | 63,452 | $7.30 | $463.20kSell |
Stuart Naylor | CHIEF DEV. OFFICER | 2025-02-21 | 23,500 | $7.30 | $171.55kSell |
Richard Giroux | CFO COO | 2025-01-21 | 24,000 | $6.29 | $150.96kSell |
Richard Giroux | CFO COO | 2025-01-14 | 13,219 | $5.77 | $76.27kSell |
Robert K. Zeldin | CHIEF MEDICAL OFFICER | 2025-01-14 | 15,149 | $5.77 | $87.41kSell |
Robert J. Wollin | GENERAL COUNSEL AND SECRETARY | 2025-01-14 | 2,909 | $5.77 | $16.78kSell |
Alexandria Forbes | PRESIDENT CEO | 2025-01-14 | 15,863 | $5.77 | $91.53kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Perceptive Advisors LLC | 15.95% | 12,581,103 | $95.11M | Institution |
Perceptive Advisors LLC | 15.89% | 12,531,103 | $94.74M | Insider |
Sanofi | 15.47% | 12,197,737 | $92.21M | Insider |
Sanofi | 15.47% | 12,197,737 | $92.21M | Institution |
Johnson Johnson | 8.42% | 6,641,064 | $50.21M | Insider |
Johnson Innovatio Johnson | 8.42% | 6,641,064 | $50.21M | Insider |
Johnson Johnson | 8.42% | 6,641,064 | $50.21M | Institution |
Perceptive Life Sciences Master Fund Ltd | 7.62% | 6,007,746 | $45.42M | Insider |
Adage Capital Partners GP LLC | 6.38% | 5,034,578 | $38.06M | Institution |
Prosight Management LP | 5.57% | 4,390,837 | $33.19M | Institution |